Chong Kun Dang Bio Swings to Loss in Q1... Sales and Profitability Both Decline
From Last Quarter's Profit to a Loss of 1.7 Billion Won
Profitability Plummets Sharply Year-over-Year
Chong Kun Dang Bio posted a loss in the first quarter of this year. Sales declined, and operating profit rapidly deteriorated from a surplus to a deficit.
On April 24, Chong Kun Dang Bio announced through a public disclosure that its sales for the first quarter of 2026 amounted to 40,695 million won. This represents a decrease of 3.6% compared to the previous quarter (42,521 million won), and a 4.3% decrease year-over-year.
Hot Picks Today
"I Wish I Could Sleep": Frozen Meals, Two Hours...
- The Quoted 800,000 Won, the Bill Was 5 Million... Bereaved Families of 'No-Funer...
- "You Can Only Have This in Korea": Which National Museum Cafe Menu Is Captivatin...
- Tragedy in Luxury Apartment: Woman in Her 20s Found Dead, Suspect Identified
- "Never Hike Alone as a Woman" "Even Two Are at Risk"... Growing Fear of Crime on...
The decline in profitability was even steeper. The company posted an operating loss of 1,707 million won, turning from an operating profit of 109 million won in the previous quarter to a deficit. Compared to the same period last year, when it recorded an operating profit of 2,087 million won, the decline was even more significant. Both pre-tax income and net income also turned negative. Income before corporate tax from continuing operations recorded a loss of 2,039 million won, while net income for the period was a loss of 2,029 million won.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
